These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 8240353)

  • 1. CX-397, a novel recombinant hirudin analog having a hybrid sequence of hirudin variants-1 and -3.
    Komatsu Y; Misawa S; Sukesada A; Ohba Y; Hayashi H
    Biochem Biophys Res Commun; 1993 Oct; 196(2):773-9. PubMed ID: 8240353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
    Komatsu Y; Inoue Y; Goto Y; Fukazawa T; Hayashi H
    Thromb Haemost; 1999 Feb; 81(2):250-5. PubMed ID: 10064001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hirudin and hirudin-based peptides.
    Stone SR; Maraganore JM
    Methods Enzymol; 1993; 223():312-36. PubMed ID: 8271960
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-hirudin monoclonal antibodies directed toward discontinuous epitopes of the hirudin amino-terminal and epitopes involving the carboxy-terminal hirudin amino acids.
    Koch C; Whitechurch O; Cordier P; Roitsch C
    Anal Biochem; 1993 Oct; 214(1):301-12. PubMed ID: 7504411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
    Johnson PH; Sze P; Winant RC; Hudson D; Underhill P; Lazar JB; Olsen C; Almquist R
    Haemostasis; 1991; 21 Suppl 1():41-8. PubMed ID: 1894196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recent developments in the biochemistry of hirudins].
    Walsmann P
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):821-30. PubMed ID: 2483699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and evaluation of recombinant hirudin.
    Courtney M; Loison G; Lemoine Y; Riehl-Bellon N; Degryse E; Brown SW; Cazenave JP; Defreyn G; Delebassee D; Bernat A
    Semin Thromb Hemost; 1989 Jul; 15(3):288-92. PubMed ID: 2688101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant hirudin: genetic engineering and structure analysis.
    Märki WE; Grossenbacher H; Grütter MG; Liersch MH; Meyhack B; Heim J
    Semin Thromb Hemost; 1991 Apr; 17(2):88-93. PubMed ID: 1771417
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombin effects of native and recombinant hirudins.
    Markwardt F; Stürzebecher J; Glusa E
    Biomed Biochim Acta; 1990; 49(5):399-404. PubMed ID: 2271010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of site specific amino acid exchanges in hirudin on the thrombin-hirudin interaction.
    Köhler S; Dodt J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):24-9. PubMed ID: 2459027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification and characterization of multigram amounts of a recombinant hybrid HV1-HV2 hirudin variant expressed in Saccharomyces cerevisiae.
    Lehman ED; Joyce JG; Bailey FJ; Markus HZ; Schultz LD; Dunwiddie CT; Jacobson MA; Miller WJ
    Protein Expr Purif; 1993 Jun; 4(3):247-55. PubMed ID: 8518563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fermentation, purification and identification of recombinant RGD-Hirudin].
    Mo W; Zhang YL; Wang LS; Yang XY; Song HY
    Sheng Wu Gong Cheng Xue Bao; 2004 Jan; 20(1):126-9. PubMed ID: 16108503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemistry and genetic engineering of hirudin.
    Johnson PH; Sze P; Winant R; Payne PW; Lazar JB
    Semin Thromb Hemost; 1989 Jul; 15(3):302-15. PubMed ID: 2688103
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction of hirudin with the dysthrombins Quick I and II.
    Stone SR; Schmitz T; Henriksen RA; Hofsteenge J; Dodt J
    Biochemistry; 1991 Jul; 30(26):6392-7. PubMed ID: 2054344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and characterization of a novel staphylokinase variant with thrombin-inhibitory activity.
    Wang M; Wang Y; Wang J; Zou M; Liu S; Xu T; Cai X; Wu C; Wang J; Xu D
    Biotechnol Lett; 2009 Dec; 31(12):1923-7. PubMed ID: 19685208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reevaluating the effects of tyrosine iodination of recombinant hirudin on its thrombin inhibition kinetics.
    Komatsu Y; Hayashi H
    Thromb Res; 1997 Aug; 87(4):343-52. PubMed ID: 9271811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immobilized hirudin and hirudin-based peptides used for the purification of recombinant human thrombin prepared from recombinant human prothrombin.
    Fischer BE; Mitterer A; Schlokat U; Grillberger L; Reiter M; Mundt W; Dorner F; Eibl J
    Protein Expr Purif; 1996 Sep; 8(2):167-74. PubMed ID: 8812854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel hirudin variants from the leech Hirudinaria manillensis. Amino acid sequence, cDNA cloning and genomic organization.
    Scacheri E; Nitti G; Valsasina B; Orsini G; Visco C; Ferrera M; Sawyer RT; Sarmientos P
    Eur J Biochem; 1993 May; 214(1):295-304. PubMed ID: 7685281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of in vitro clot growth by r-hirudin is more effective and longer sustained than by an analogous peptide.
    Römisch J; Stöhr HA; Stauss H; Koschinsky R; Stüber W; Pâques EP
    Thromb Haemost; 1994 Mar; 71(3):320-4. PubMed ID: 8029796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant hirudin: kinetic mechanism for the inhibition of human thrombin.
    Stone SR; Hofsteenge J
    Protein Eng; 1991 Feb; 4(3):295-300. PubMed ID: 1857714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.